10.1. Dynein and viral replication {#s0010}
==================================

The Dynein complex is a microtubule (MT)-associated protein complex that mediates retrograde transport of macromolecules in the cytoplasm [@bib2]. It is a 1.6-MDa complex built around two copies of ATPase energy-generating subunits called Dynein heavy chains (DHCs). Two Dynein intermediate chains (DICs) and two light intermediate chains (LICs) bind directly to the DHCs. Three Dynein light chains (DLCs) serve as Dynein adapter proteins, such as DLC 1 (DYNLL1, LC8, DLC1), DLC Tctex-type 1 (DYNLT1), and p150^Glued^, which have been implicated in cargo recruitment to Dynein complex during retrograde transport [@bib3], [@bib4], [@bib5], [@bib6]. More details on Dynein function are found below and in accompanying chapters. Dynein involvement in virus replication has been well studied. Usually investigations have centered on major questions of viral capsid translocation in the cell. For neurotropic viruses such as herpesviruses that require transit through long distances in differentiated and extended cells this is intuitively obvious [@bib7], [@bib8]. In this case, herpesvirus will interact on de *novo infection* and after gaining entry in the cell with Dynein subunits to transit toward the nucleus. The requirements for active transport are equally substantial for several other viruses such as human immunodeficiency virus type 1 (HIV-1) and recent investigations into other retroviruses such as murine leukemia virus (MLV), and reviewed extensively in Ref. [@bib9], [@bib10], [@bib11]. Previous studies have implicated DYNLL1 and DYNLT1 proteins in different aspects of virus replication (reviewed in Ref. [@bib12]). For example, DYNLL1 interacts with a rabies virus phosphoprotein and contributes to the viral gene expression [@bib13], [@bib14], [@bib15]. Also, DYNLL1 interacts with the CA protein of bovine immunodeficiency virus (BIV) and contributes to retrograde transport [@bib3]. DYNLT1 interacts with the CA protein of human papilloma virus type-16 (HPV-16) and contributes to the HPV-16 replication at an unknown replication step(s) [@bib16]. Unlike the DYNLL1 and DYNLT1, the potential involvement of p150^Glued^ in the replication of viruses is currently not very clear. However, the component of the Dynein complex, Dynactin associates to p150^Glued^ [@bib17] and has been implicated in viral replication and the retrograde transport of viruses [@bib6], [@bib18], [@bib19].

10.2. Kinesins {#s0015}
==============

The activity of kinesins co-opted by viruses is worthy of note. The tug-of-war that exists opposing motors, Kinesin and Dynein motors, is a precept that is generally accepted in the cell biology field. Morphological switches mediated by specific interactions with organelles and motor proteins will likely determine trafficking polarity in cells and the winner in the Dynein--Kinesin tug-of-war [@bib8], [@bib20], [@bib21] especially since both motor proteins occupy intracytoplasmic vesicles, and virus capsids too, and cooperate to determine directionality [@bib8], [@bib10], [@bib22]. This is clearly the case for retroviruses such as Mason--Pfizer Simian Virus (M-PSV) that interacts with the DLC (DYNLT1) Tctex-1 to target to intracellular viral assembly sites adjacent to the nucleus, at the microtubule organizing center (MTOC) [@bib23], [@bib24]. In contrast to the directed capsid assembly of the lentivirus, HIV-1, at the plasma membrane, capsid assembly of M-PSV occurs near the MTOC. A morphogenetic switch, mediated by an interaction between de novo synthesized Gag and DYNLT1, allows for M-PSV to acquire bilipid envelope at the plasma membrane, likely by the activity of MT + end motors such as Kinesin [@bib1], [@bib24]. Interestingly, a single point mutation in the Dynein-binding domain not only prevents DYNLT1 binding, but also changes the site of assembly to that exhibited by HIV-1, by targeting viral capsid assembly to the plasma membrane. The presence of viral proteins such as retroviral Gag as well as host proteins on endosomal membranes may constitute cargo that is available for directed transport on MTs toward viral assembly sites. Interactions of viral proteins with Dynein mediators such as Lissencephaly-1 (LIS-1) and other host proteins [@bib25], [@bib26], [@bib27] could also provide information to switch from a minus-end to plus-end motor directed traffic. Curiously, the HIV-1 regulatory protein, Tat, enhances MT polymerization [@bib28] and interacts with LIS-1 protein [@bib29], whereas HIV-1 Rev, Vaccinia virus, and ASFV were reported to break down MTs [@bib30], [@bib31], [@bib32]. Recent work demonstrates in fact that PKA phosphorylates cytoplasmic Dynein at a novel site in the Dynein light intermediate chain 1 (LIC1) that is essential for Dynein binding to the hexon capsid subunit and for virus motility [@bib33], [@bib34]. This posttranslational modification mediates an adenovirus-derived switch that promotes late endosome/lysosome dispersal thereby inducing a tempered specific dispersal of late endosome/lysosomes. This was shown to be due to the disruption of the LIC1 interaction with the Rab7-interacting lysosomal protein (RILP). At the other end of the virus replication cycle, late events during HIV-1 replication for example are also characterized by virus-mediated disruptions in membrane trafficking. During viral egress, HIV-1 commandeers late endosome/lysosomes to promote outbound trafficking of viral components along with late endosome/lysosomes-associated factors such as mTORC1 and the viral RNA (Alessandro Cinti & A.J. Mouland, unpublished; [@bib35], [@bib36]). Co-opting these membranes that bear characteristics of late endosome/lysosomes, containing LAMP-1 and other integral membrane markers, may have the obvious result of promoting correct targeting to virus assembly domains. Topologically, the eventual fusion of these vesicles at the plasma membrane should result in localization to the inner plasma membrane followed by outward, virus budding (see Ref. [@bib1]). Interestingly, another recent study demonstrated that phagosome maturation was impaired in HIV-1--infected human macrophages. Testing pathogen clearance in these cells, it was found that the accessory Vpr gene product interacted with EB1 (plus-end MT tracking proteins), p150^Glued^, and the DHC thereby blocking EB1 loading on Dynein motors on the plus ends of MTs that is necessary for phagosome maturation [@bib9], [@bib37] ([Fig. 10.1](#f0010){ref-type="fig"} ). These observations will necessarily have a major bearing on pathogenesis but as well as on the cell's ability to ward off other opportunistic infections, which is the case in mid- to late-stage infections. The effects of HIV-1 Vpr in this case might be reflected in patients as opportunistic coinfections take hold in largely untreated or drug-naive patients in the developing world [@bib38]. Lastly, the RILP--Dynein interaction ([Fig. 10.1](#f0010){ref-type="fig"}) was found to be critical for HCV intracellular trafficking. Virus-mediated cleavage of RILP generates an N-terminally truncated protein that dissociates the Dynein motor from viral cargo over the course of infection. The resulting preference for outbound trafficking of viral cargo promotes the transition from the intracellular-predominant to the secretion-predominant phenotype that corresponds to the production of the cleaved RILP [@bib39]. See [Table 10.1](#t0010){ref-type="table"} .Figure 10.1Early and late virus replication steps are characterized by virus subversion of Dynein and associated factors.During the replication cycle, viral particles (i.e., viral proteins and complexes) need to be transported within host cells. In the early (A) and late (B) (postreplication) stages, the trafficking of viral components relies on the host cell cytoskeleton and molecular motors. Viruses require minus-end--directed Dynein motor complex for retrograde transport on microtubules (from cell surface toward the nucleus) (A) and Dynein in addition to kinesins for the anterograde transport toward the plasma membrane (B). By interacting with different Dynein complex factors, viruses can positively (in green) or negatively (in red) regulate a number of cellular processes including but not limited to viral restriction, nuclear targeting and integration, autophagosome maturation, innate immunity, alkalinization, and localization of late endosome/lysosomes and mTOR positioning. Details on the specific viral--host (Dynein complex) interactions are discussed/provided in the text and listed in [Table 10.1](#t0010){ref-type="table"}.Table 10.1Viruses that interact with Dynein components during replication to 2017Virus[a](#tbl10_1fna){ref-type="table-fn"}Virus interaction domainDynein componentReferencesAdeno-Associated virusCapsidDynein[@bib95]AdenovirusCapsidDynein light and light intermediate chain IC and LIC1[@bib95], [@bib96], [@bib97], [@bib98], [@bib99], [@bib100], [@bib101]FIP-1TCTEL1African Swine Fever virusP54 (13 amino acid motif)DLC-8[@bib19], [@bib102]Bovine Immunodeficiency virusCapsidDLC-8[@bib3]EbolavirusVP35DLC-8[@bib103]Hantaan virusUnknownUnknown[@bib104]Hepatitus B virusUnknownUnknown[@bib105]Hepatitus C virusUnknownUnknown[@bib106].Hepatitus E virusVp13Dynein[@bib107]Herpes Simplex Virus 1VP26 capsidRP3, Tctex-1[@bib6], [@bib8], [@bib48], [@bib108], [@bib109], [@bib110], [@bib111], [@bib112]Equine HerpesvirusUnknownUnknown (acetylated tubulin)[@bib82]Kaposi's Sarcoma Herpesvirus (HHV-8)UnknownUnknown (acetylated tubulin)[@bib83]Mason-Pfizer Simian virusMatrixDYNLT1 (Tctex-1)[@bib23], [@bib24],Bovine Immunodeficiency virusCapsidLC8[@bib3]Human Foamy VirusCapsidLC8[@bib49]Human immunodeficiency virus type 1Preintegration complexDynein[@bib35], [@bib50], [@bib113]Human papillomavirus (HPV)MINOR CAPSID L2DYNLT1 and DYNLT3[@bib114], [@bib115]PoliovirusReceptor CD155Tctex-1[@bib116], [@bib117], [@bib118], [@bib119]Rabies virusP PhosphoproteinDYNLL (LC8)[@bib13], [@bib14], [@bib15], [@bib120], [@bib121], [@bib122]SirevirusHopie Gag extensionDLC-8[@bib123]Vaccinia virusUnknownUnknown[@bib32], [@bib124], [@bib125];Rabies viruspolymerase LDLC-1[@bib126]Murine leukemia virus (MLV)Preintegration complexp50[@bib56], [@bib127]Porcine circovirus (PCV2)capsid (Cap)DIC-1, Dynein light chain, DYNLL1[@bib60], [@bib128]Ebola virus (EBOV)VP35Dynein light chain (LC8)[@bib103]Human immunodeficiency virus type 1VprDynein light chain protein, DYNLT1,[@bib129]Human immunodeficiency virus type 1VprEB1, p150^Glued^, and DHC[@bib37]Human immunodeficiency virus type 1Integrase (IN)Dynein light chain 1 (DYNLL1)[@bib78]Hepatitus C virusUnknownRILP[@bib39]Influenza A virusUnknownDynein and dynactin[@bib130]Foot-and-mouth disease virus (FMDV)Nonstructural protein 3ADynactin 3[@bib131]Mouse Polyomavirus (MPyV)UnknownDynein[@bib132]Rhesus rhadinovirus (RRV)UnknownDynein[@bib133]Pseudorabies virus (PRV)Viral protein 1/2 (VP1/2)DIC and p150^Glued^[@bib7][^1]

10.3. Innate immunity, the Rabs, Rab7-interacting lysosomal protein, and vesicular transport {#s0020}
============================================================================================

Following acute infection, the host cells mount a formidable innate response to infection that is not specific and usually leads to a burst of antiviral cytokine and interferon gene expression. This response includes the activity of well-described pattern recognition receptors and ensuing signaling to transcriptional activation of interferon stimulated genes, cytokines, and interferons. However, as immune-cell tropic viruses target T, B, and myeloid cell types, immunity is compromised [@bib40]. Moreover, responses to acute infection in macrophages as well as other host cells such as dendritic cells appear to be compromised by a variety of mechanisms. One is a virus-mediated defect in viral antigen processing. By preventing autophagosome peptide generation and the presentation of antigen at the cell surface represents one way in which HIV-1, and likely other viruses, evade the host recognition [@bib41]. Small Rab GTPases generally spike and define vesicles in the cell from early to late endosomes. Early endosomes will acidify following endocytosis and late endosomes that are generally actively directed to juxtanuclear positions carry Rab5 and then exchange with Rab7. Rab7-associated proteins such as RILP play particular roles in mediating the interaction of cargo with the Dynein motor via its association to p150^Glued^. RILP appears to be central to a number of processes involving intracellular trafficking of late endosome/lysosomes, membrane fusion events (e.g., endoplasmic reticulum (ER)--late endosome) and as described below, in immune responses and antigen presentation during virus infection. It remains a valuable tool in cell biology studies as the overexpression leads to the redistribution of late endosomes/lysosomes to the juxtanuclear region, the MTOC. This observed phenotype is evidence of a direct role in tethering the Dynein motor via the Dynein subunit p150^glued^ and Rab7 expressed on late endosome/lysosomes. Expression of Dynein-interacting mutants leads to the release of late endosome/lysosomes with evidence that virus cargo is affected by RILP mutagenesis, to likely involve Dynein motor function. This was brought to the forefront of immunology in light of the involvement of Dynein in the presentation of HLA Class II antigen presentation. In multiple sclerosis for instance in which there is a susceptibility locus, late endosomal vesicle biogenesis, and HLA Class antigen presentation were shown to be dependent on CLEC16. CLEC16's interaction with RILP and the homotypic fusion and protein sorting--tethering complex [@bib42] and perturbed Dynein retrograde transport led to a blockade of the recruitment of MHC Class II antigens to the perinuclear region. This is mentioned here to demonstrate that while a defect in the functioning of the host gene leads to human disease, MHC Class II antigen presentation is also crucial to mount a defense against HIV-1 and other viruses. Antigens derived from within infected cells, in contrast to extracellular delivery of virus-specific antigens from virally produced cells, are also shuttled intracellularly. Defects induced by virus infection lead to intracellular trafficking deficiencies and in this type of scenario, a role for autophagic vesicles was brought to light in dendritic cells to activate HIV-1 specific CD4^+^ T cells [@bib41]. While autophagy was not critical to Ag presentation to CD4^+^ T cells, targeting of HIV-1 specific antigens to autophagosomes nevertheless enhances virus-specific T cell antigen presentation. The MT-associated dendritic cell protein L chain (LC3) played a key role in this event, likely propelled by the Dynein motor for recruitment to juxtanuclear membrane fusion and autophagy processes.

10.4. Dynein, viruses, and the innate immune response {#s0025}
=====================================================

Many viruses hijack the cellular machinery for their retrograde transport during the early stages of their replication cycle, as was reviewed previously by us and others [@bib1], [@bib10], [@bib43], [@bib44]. In particular, multiple viruses subvert the MT network and MT-associated molecular motors; examples include adenoviruses [@bib45], [@bib46], parvoviruses [@bib47], herpes simplex virus [@bib8], [@bib48], and retroviruses [@bib49]. HIV-1 interactions with MTs and Dynein in the early infection stages have been relatively thoroughly investigated. A landmark live cell microscopy study that made use of fluorescently labeled individual viral particles yielded fascinating movies of HIV-1 traveling along MTs en route toward the MTOC [@bib50]. Following MT-dependent transport, HIV-1 cores accumulate in the vicinity of the MTOC and then at nuclear pores [@bib50], [@bib51], [@bib52].

Inspired by previous findings with other viruses, HIV-1 retrograde transport was proposed early on to be mediated by the Dynein motor, as evidenced by an accumulation of viral particles in the cell periphery following microinjection of anti-Dynein antibodies [@bib50]. However, these results were descriptive in nature, offering no link between Dynein and MT functions and the infectivity of incoming HIV-1. Indeed, when functional studies were undertaken, they yielded rather conflicting results. In HeLa cells, for instance, none of several genetic or pharmacological approaches to interfere with Dynein or MTs had a significant impact on infectivity, even when they had a clear effect on HIV-1 intracellular movements [@bib53], [@bib54], [@bib55]. Treatment with nocodazole and depletion of the DHC similarly did not affect the infectivity of another lentivirus, SIVmac, in human and nonhuman primate cells [@bib53], [@bib54], and also had no effect on the infectivity of MLV, a gammaretro virus. We take these sobering observations as evidence that identifying the specific cytoskeleton and transporter subunit components involved is necessary to fully understand the mechanisms of retrograde transport for any given virus. Indeed, a specific DLC, DYNLRB2, was recently found to mediate MLV retrograde transport, and its expression levels correlated with MLV infectivity [@bib56]. Likewise, a kinesin-1 adaptor, Fasciculation and Elongation Factor zeta 1 was recently found to be important for HIV-1 retrograde transport and infectivity [@bib57]. In addition, not all MTs are alike, and HIV-1 seems to promote the formation of and then use "stable" MTs, characterized by a state of decreased polymerization/depolymerization, which renders them resistant to nocodazole (explaining why multiple investigators saw little to no effect of nocodazole on HIV-1 infectivity, and see below) [@bib58]. Human herpes simplex virus 1 is transported on long distances toward the nucleus of sensory neurons through an association with MTs initiated by binding to protein complexes called "+TIPs," which comprise the Dynein interactor dynactin-1 [@bib59]. The capsid protein of circoviruses interacts with the intermediate chain 1 of Dynein complexes for its retrograde transport [@bib60]. Thus, viruses accomplish retrograde transport by interacting with Dynein motors, and possibly other motor complexes, using a variety of molecular mechanisms. Some viruses may modulate the dynamics and functions of MTs themselves, in addition to hijacking molecular motors.

The reliance of viruses on MT-dependent retrograde transport provides a weak spot that may be exploited by innate immune mechanisms to target these intracellular parasites. Indeed, several type 1 interferon-induced innate effectors act in the early postentry stages of viral infections [@bib61]. One would expect some of these effectors to intercept viruses while they associate with MTs. This idea has been explored in the context of the inhibition of retroviruses by the tripartite motif (TRIM) protein family member TRIM5α. This E3 ubiquitin ligase forms cytoplasmic bodies in which inhibition-sensitive viruses are trapped, disassembled, and degraded [@bib62]. Because these large cytoplasmic structures resemble aggresomes, their interactions with MTs were investigated soon after the discovery of their antiretroviral properties. It was found that indeed, TRIM5α cytoplasmic body subcellular localization is dependent on functional MTs [@bib63]. Accordingly, the presence of functional MTs and Dynein motors was shown to be important for the inhibition of retroviruses by TRIM5α [@bib54], [@bib55]. TRIM proteins form a large family of proteins of which many have antiviral properties [@bib64] and, on the other hand, often show an affinity for MTs [@bib65]. Therefore, it is entirely possible that TRIM5α is the tip of the iceberg and that more examples of molecular motors and MTs being essential to the antiviral roles of the TRIM proteins will be uncovered in the future.

10.5. IFITM3 and VAP-A {#s0030}
======================

An additional restriction factor, that is also interferon-inducible, whose function depends on Dynein and Dynein-associated factors, is the interferon-inducible transmembrane protein 3 (IFITM3). IFITM3 has antiviral activity and depends on lipid metabolism in the cell. While many viruses depend on lipid scaffolds such as lipid rafts for assembly, viruses also depend on cholesterol dynamics for early and late infection. Interestingly, perturbation of cholesterol homeostasis can block viral entry steps (e.g., Ref. [@bib66]). IFITM3 was shown to interact with VAP-A, a membrane-associated protein on the ER, on tight junctions and synaptic vesicles. Humans contain two VAP genes, VAP-A and VAP-B. VAP-A, as well as B, has an MSP domain at the N terminus, followed by a coiled coil region and ending in transmembrane domain that anchors the protein into the ER membrane. The MSP region has been shown to interact with FFAT domains commonly found on oxysterol binding proteins cholesterol sensor proteins, such as ORP1L. VAP-A has also been shown to interact with viral proteins from both HCV and Norwalk viruses and has been shown to modulate viral transport [@bib67], [@bib68]. Prosser et al. determined that VAP-A creates a block in vesicular trafficking from the ER to the Golgi network and resolved the block by overexpressing VAP-A as well as mutants of this protein [@bib69]. The overexpression also had dramatic effects on IFITM3 restriction activity, in that this blocked its interaction with ORP1L [@bib70] thereby preventing the fusion of intraluminal virion-containing vesicles with endosomal membranes and thereby blocking virus release.

Interestingly, Rocha et al. [@bib71] found that purified VAP-A was able to remove the C25 fragment of p150^glued^ from preassembled, and purified, Rab7--RILP--ORP1L complexes on metal affinity beads. Through in vivo experiments they determined that late endosome/lysosomes were often in contact with the ER membrane and the conformation of ORP1L could dictate whether there were more or less membrane contact sites. When cholesterol is high, ORP1L takes on a conformation where the FFAT domain is sequestered and therefore cannot interact with ER-bound VAP-A. As a consequence, Dynein--p150^glued^--RILP promotes juxtanuclear localization of late endosome/lysosomes. In contrast, Dynein function is blocked when ORP1L is in a low cholesterol conformation with its FFAT domain exposed to interact with the MSP domain of the ER-associated, VAP-A. Importantly, HIV-1 subverts the cholesterol sensing mediated by ORP1L by maintaining peripheral localization of late endosomes/lysosomes not only impacting on HIV-1 protein and RNA localization but also on mTORC1 positioning and activity [@bib71a] ([Fig. 10.1](#f0010){ref-type="fig"}).

As an integral component of late endosome/lysosomal membranes, the small GTPase, Rab7, which associates to RILP and the Dynein p150^Glued^, was shown to play a critical role in viral restriction mediated by the bone marrow stromal antigen 2 or Tetherin host protein. Tetherin, a lipid raft-associated protein that is encoded by the *bst2* gene, is the last restriction factor discussed in this chapter. Tetherin, as the name implies promotes tethering of mature virus particles to the outer plasma membrane. Interestingly, HIV-1 and other viruses counter the innate activity of this host factor to allow for budding viruses to be released from the cell surface. While intense research into this factor has yielded almost a complete understanding of structure and mechanism of action, recent work has now identified a role of the Dynein effector, Rab7a, in enhancing Tetherin restriction activity in virus release and budding [@bib34]. Similar to findings for HCV, this discovery suggests that endosomal sorting somehow influences the virus restriction activity of Tetherin, mediated by Dynein, thereby promoting both egress of late endosome/lysosomes and mature virus particle release from the cell surface, but this relationship will require further substantiation.

10.6. Dyneins and nuclear integration of viral DNA {#s0035}
==================================================

On entry into the host cell, viruses translocate within the cytoplasm to sites of replication, to a perinuclear region and can use this as a scaffold to enter the nucleus in viruses that require a nuclear intermediate. In a manner identical to host cell vesicles or macromolecular complexes that are transported intracellularly, viral translocation is not achieved by passive diffusion but by energy-dependent, active transport mechanisms. Many viruses are transported along MTs and interact with various cellular cofactors including factors associated to the Dynein motor complex, as described herein. During the early stages of HIV-1 replication following acute infection for instance, the viral genomic RNA is reverse-transcribed into a complementary DNA and forms a preintegration complex, which undergoes intracytoplasmic retrograde transportation and nuclear import, and subsequently integrates into the host cell genome (reviewed in Ref. [@bib72], [@bib73]). During these processes, different viral proteins interact with and utilize various cellular proteins for replication. Genome-wide si/shRNA screening and other functional studies have uncovered a large number of host proteins with putative roles in HIV-1 replication (reviewed in Ref. [@bib74], [@bib75], [@bib76]). However, molecular events associated with HIV-1 retrograde transport in the cytoplasm are still not well understood. Interestingly, several studies have indicated that a functional Dynein complex or intact MT network is essential for efficient HIV-1 uncoating following entry [@bib53], [@bib77], [@bib78] and retrograde transport toward the nucleus prior to nuclear integration [@bib50], [@bib77], [@bib79].

Recent studies have demonstrated that the inhibition of DHC (DYNC1H1) by siRNA or the disruption of the intact MTs by nocodazole treatment delayed the uncoating process during HIV-1 infection [@bib53], [@bib77]. This suggests that the Dynein complex and intact MT network facilitate the HIV-1 uncoating [@bib53], [@bib77]. Another study showed that the DYNLL1-KD or the disruption of HIV-1 integrase/DYNLL1 interaction resulted in a significant loss of reverse transcription and an increase in the rate of HIV-1 uncoating [@bib78]. However, it is still unclear whether it is the Dynein complex--associated DYNLL1 that promotes HIV-1 reverse transcription and uncoating. Interestingly, a previous study suggested that DYNLL1 may not be able to mediate cargo recruitment to the Dynein complex [@bib80]. Therefore, further investigation is required to elucidate the roles of DYNLL1 and Dynein complex or MT network in HIV-1 replication.

The requirement of HIV integrase/DYNLL1 for the proper uncoating of HIV-1 and its reverse transcription has also been demonstrated [@bib78]. However, the molecular mechanisms of this virus--host interaction that contributes to the proper uncoating of HIV-1 and reverse transcription will require further characterization. DYNLL1 has been shown to bind to a number of cellular proteins and facilitates protein complex formation [@bib81]. Therefore, it can be speculated that cellular proteins may be recruited to the reverse transcription complex via DYNLL1 interaction, which helps HIV-1 RTC reorganization and/or stabilization, and consequently contributes to proper uncoating and/or efficient reverse transcription. Conversely, the disruption of HIV-1 integrase/DYNLL1 interaction could lead to aberrant uncoating and the formation of unstable RTC, resulting in low levels of HIV-1 reverse transcription. These findings provide evidence for a possible alternative mechanism by which HIV-1 integrase facilitates the proper uncoating and efficient viral reverse transcription.

10.7. Posttranslationally modified microtubules and Dynein {#s0040}
==========================================================

A major theme in virus-cell biology is the ability of the virus to commandeer factors to enable all aspects of the replication cycle. A variety of studies have focused attention on how viruses traffic on cytoskeletal elements. Notable interactions include motor protein translocation on MTs with cargo, including vesicles and viral components such as RNPs and incoming capsids. Indeed, these are critical to the establishment of infection. Nevertheless, recent work has uncovered that viruses will utilize more stable MTs that are modified posttranslationally, either by acetylation or tyrosination to confer enhanced stability and perhaps secure efficient viral targeting. This would contribute to the delivery of viral components to destinations in the cells during both ingress and egress. For example, resistance to the effects of the MT destabilizing agent nocodazole as mentioned above led to investigations on characterizing subpopulations of MTs that resisted nocodazole treatment. Indeed, several herpesviruses were found associated to acetylated MTs [@bib82], [@bib83]. Recent evidence for retroviruses also demonstrates that there is a preference for acetylated and detyrosinated stable MTs early in infection [@bib58], for which Dynein activity was shown to be critical [@bib50]. As such, recent work on the specific roles of these posttranslationally modified MTs [@bib84], [@bib85] highlights earlier work from several groups that demonstrate in vivo and in live cell experiments that retroviruses require late endosome/lysosomes for intracellular trafficking [@bib35], [@bib36], [@bib86]. Future work focusing on the selectivity achieved by viruses for subpopulations of MTs during both ingress and egress should be informative.

10.8. Emerging viruses and co-opting of Dynein {#s0045}
==============================================

Recent global threats to human health from emerging viruses have fueled intense efforts into the understanding of virus molecular and cellular biology. Emerging viruses include Ebola, severe acute and Middle East respiratory syndrome Coronavirus (SARS/MERS-CoV), Zika, and Chikungunya viruses, among others [@bib87]. Despite new vaccines that are in the pipeline [@bib88], [@bib89], [@bib90], scant new information on these viruses exist, especially in regard to how they commandeer host Dynein and associated machineries. For example, Ebola virus was shown to interact with the highly conserved 8 kDa cytoplasmic light chain (LC8), like many viruses ([@bib91]; reviewed in Ref. [@bib1]) but few details at the time were available. Current evidence indicates that this interaction indeed enhances RNA replication of this highly pathogenic virus [@bib91]. Furthermore, Ebola replication was found to be sensitive Dynein as the expression of mutants of the cholesterol sensor, ORP1L, which acts as a regulator of Dynein motor binding to RILP, dramatically affected virus output [@bib92]. In contrast, scant evidence for an association between SARS-CoV and Dynein motor complexes is available. Indeed, the SARS-CoV Envelope membrane--associated Envelope protein brought down the DHC, among other proteins; but little else is understood about this potential interaction [@bib93]. Members of the flaviviridae including West Nile, HCV, Dengue, and Zika among others have each their own prevalence worldwide, the last two of which are considered as the current emerging threats to human health [@bib94], in North America and elsewhere. There are little data on virus--host interactions between Zika and components of the Dynein machinery in mid-2017. Nevertheless, as Zika infects several cell types including neuronal cell lineages, and its study does not require high-level biosafety containment, a role for Dynein, as is the case for HCV [@bib39], in executing virus-mediated programs will likely be revealed through current and intense further investigation.

Major outstanding questions {#s0050}
===========================

In light of the characterized interplay between viruses and molecular motor proteins such as Dynein and Kinesin, several questions remain, but are not necessarily readily answered. These include:•Are virus--Dynein interactions druggable in selective and specific ways?•Can the targeting of virus--Dynein interactions help in enhancing immune responses to infection?•In what other ways do viruses commandeer intracellular trafficking machineries for early and late replication events?•Is the selective commandeering of stable populations of microtubules a general feature of virus-mediated subversion of the host cell?
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[^1]: Highlighted columns indicate listings since first edition of this chapter (1). Most viruses are discussed in text.
